Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives

World Journal of Gastroenterology

Volumn 21, Issue 1, 2015, Pages 21-46

  Tontini, Gian Eugenio ^a,b   Vecchi, Maurizio ^a,c   Pastorelli, Luca ^a,c   Neurath, Markus F ^b   Neumann, Helmut ^b  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Advanced endoscopic imaging; Biomarkers; Crohn's disease; Histopathology; Inflammatory bowel disease unclassified; Ulcerative colitis

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CLINICAL FEATURE; COLONOSCOPY; CROHN DISEASE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EPIGENETICS; ESOPHAGOGASTRODUODENOSCOPY; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; INFLAMMATORY BOWEL DISEASE; METABOLOMICS; PROGNOSIS; PROTEOMICS; SURGICAL APPROACH; SYMPTOMATOLOGY; TREATMENT OUTCOME; ULCERATIVE COLITIS; COLITIS, ULCERATIVE; DIGESTIVE SYSTEM EXAMINATION; PREDICTIVE VALUE;

COLITIS, ULCERATIVE; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84920901942     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i1.21     Document Type: Article

References (378)

1. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54.e42; quiz e30 [PMID: 22001864 DOI: 10.1053/j.gastro.2011.10.001]
2. Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV, Tysk C, O'Morain C, Moum B, Colombel JF. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut 2013; 62: 630-649 [PMID: 23335431 DOI: 10.1136/gutjnl-2012-303661]
3. Burisch J, Jess T, Martinato M, Lakatos PL. The burden of inflammatory bowel disease in Europe. J Crohns Colitis 2013; 7: 322-337 [PMID: 23395397 DOI: 10.1016/j.crohns.2013.01.010]
4. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 1785-1794 [PMID: 21530745 DOI: 10.1053/j.gastro.2011.01.055]
5. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, Jewell DP, Karban A, Loftus EV, Peña AS, Riddell RH, Sachar DB, Schreiber S, Steinhart AH, Targan SR, Vermeire S, Warren BF. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 Suppl A: 5A-36A [PMID: 16151544]
6. Annese V, Daperno M, Rutter MD, Amiot A, Bossuyt P, East J, Ferrante M, Götz M, Katsanos KH, Kießlich R, Ordás I, Repici A, Rosa B, Sebastian S, Kucharzik T, Eliakim R; European Crohn's and Colitis Organisation. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 2013; 7: 982-1018 [PMID: 24184171 DOI: 10.1016/j.crohns.2013.09.016]
7. Dignass A, Lindsay JO, Sturm A, Windsor A, Colombel JF, Allez M, D'Haens G, D'Hoore A, Mantzaris G, Novacek G, Oresland T, Reinisch W, Sans M, Stange E, Vermeire S, Travis S, Van Assche G. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis 2012; 6: 991-1030 [PMID: 23040451 DOI: 10.1016/j.crohns.2012.09.002]
8. Dignass A, Van Assche G, Lindsay JO, Lémann M, Söderholm J, Colombel JF, Danese S, D'Hoore A, Gassull M, Gomollón F, Hommes DW, Michetti P, O'Morain C, Oresland T, Windsor A, Stange EF, Travis SP. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis 2010; 4: 28-62 [PMID: 21122489 DOI: 10.1016/j.crohns.2009.12.002]
9. Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn's disease in adults. Am J Gastroenterol 2009; 104: 465-483; quiz 464, 484 [PMID: 19174807 DOI: 10.1038/ajg.2008.168]
10. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2004; 99: 1371-1385 [PMID: 15233681]
11. Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ, Villanacci V, Becheanu G, Borralho Nunes P, Cathomas G, Fries W, Jouret-Mourin A, Mescoli C, de Petris G, Rubio CA, Shepherd NA, Vieth M, Eliakim R. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 2013; 7: 827-851 [PMID: 23870728 DOI: 10.1016/j.crohns.2013.06.001]
12. Meucci G, Bortoli A, Riccioli FA, Girelli CM, Radaelli F, Rivolta R, Tatarella M. Frequency and clinical evolution of indeterminate colitis: a retrospective multi-centre study in northern Italy. GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali). Eur J Gastroenterol Hepatol 1999; 11: 909-913 [PMID: 10514127]
13. Nuij VJ, Zelinkova Z, Rijk MC, Beukers R, Ouwendijk RJ, Quispel R, van Tilburg AJ, Tang TJ, Smalbraak H, Bruin KF, Lindenburg F, Peyrin-Biroulet L, van der Woude CJ. Phenotype of inflammatory bowel disease at diagnosis in the Netherlands: a population-based inception cohort study (the Delta Cohort). Inflamm Bowel Dis 2013; 19: 2215-2222 [PMID: 23835444 DOI: 10.1097/MIB.0b013e3182961626]
14. Burisch J, Pedersen N, Čuković-Čavka S, Brinar M, Kaimakliotis I, Duricova D, Shonová O, Vind I, Avnstrom S, Thorsgaard N, Andersen V, Krabbe S, Dahlerup JF, Salupere R, Nielsen KR, Olsen J, Manninen P, Collin P, Tsianos EV, Katsanos KH, Ladefoged K, Lakatos L, Björnsson E, Ragnarsson G, Bailey Y, Odes S, Schwartz D, Martinato M, Lupinacci G, Milla M, De Padova A, D'Incà R, Beltrami M, Kupcinskas L, Kiudelis G, Turcan S, Tighineanu O, Mihu I, Magro F, Barros LF, Goldis A, Lazar D, Belousova E, Nikulina I, Hernandez V, Martinez-Ares D, Almer S, Zhulina Y, Halfvarson J, Arebi N, Sebastian S, Lakatos PL, Langholz E, Munkholm P. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2014; 63: 588-597 [PMID: 23604131 DOI: 10.1136/gutjnl-2013-304636]
15. Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, Wong TC, Leung VK, Tsang SW, Yu HH, Li MF, Ng KK, Kamm MA, Studd C, Bell S, Leong R, de Silva HJ, Kasturiratne A, Mufeena MN, Ling KL, Ooi CJ, Tan PS, Ong D, Goh KL, Hilmi I, Pisespongsa P, Manatsathit S, Rerknimitr R, Aniwan S, Wang YF, Ouyang Q, Zeng Z, Zhu Z, Chen MH, Hu PJ, Wu K, Wang X, Simadibrata M, Abdullah M, Wu JC, Sung JJ, Chan FK; Asia-Pacific Crohn's and Colitis Epidemiologic Study (ACCESS) Study Group. Asia-Pacific Crohn's and Colitis Epidemiologic Study (ACCESS) Study Group. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology 2013; 145: 158-165.e2 [PMID: 23583432 DOI: 10.1053/j.gastro.2013.04.007]
16. Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, Schulz T, Stray N, Fausa O. Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway. Gut 1997; 40: 328-332 [PMID: 9135520]
17. Myren J, Bouchier IA, Watkinson G, Softley A, Clamp SE, de Dombal FT. The OMGE multinational inflammatory bowel disease survey 1976-1986. A further report on 3175 cases. Scand J Gastroenterol Suppl 1988; 144: 11-19 [PMID: 3165550]
18. Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol 2012; 46: 581-589 [PMID: 22772738]
19. Marcello PW, Schoetz DJ, Roberts PL, Murray JJ, Coller JA, Rusin LC, Veidenheimer MC. Evolutionary changes in the pathologic diagnosis after the ileoanal pouch procedure. Dis Colon Rectum 1997; 40: 263-269 [PMID: 9118738]
20. Henriksen M, Jahnsen J, Lygren I, Sauar J, Schulz T, Stray N, Vatn MH, Moum B. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study). Scand J Gastroenterol 2006; 41: 1037-1043 [PMID: 16938716]
21. Melmed GY, Elashoff R, Chen GC, Nastaskin I, Papadakis KA, Vasiliauskas EA, Liu W, Landers C, Ippoliti AF, Targan SR. Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control study. Clin Gastroenterol Hepatol 2007; 5: 602-608; quiz 525 [PMID: 17478347]
22. Kappelman MD, Moore KR, Allen JK, Cook SF. Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci 2013; 58: 519-525 [PMID: 22926499 DOI: 10.1007/s10620-012-2371-5]
23. Burisch J, Munkholm P. Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol 2013; 29: 357-362 [PMID: 23695429 DOI: 10.1097/MOG.0b013e32836229fb]
24. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001; 49: 777-782 [PMID: 11709511]
25. Peyrin-Biroulet L, Loftus EV, Colombel JF, Sandborn WJ. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 2010; 105: 289-297 [PMID: 19861953]
26. Van Limbergen J, Russell RK, Drummond HE, Aldhous MC, Round NK, Nimmo ER, Smith L, Gillett PM, McGrogan P, Weaver LT, Bisset WM, Mahdi G, Arnott ID, Satsangi J, Wilson DC. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008; 135: 1114-1122 [PMID: 18725221 DOI: 10.1053/j.gastro.2008.06.081]
27. Sjöberg D, Holmström T, Larsson M, Nielsen AL, Holmquist L, Ekbom A, Rönnblom A. Incidence and clinical course of Crohn's disease during the first year - results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005-2009. J Crohns Colitis 2014; 8: 215-222 [PMID: 24035547 DOI: 10.1016/j.crohns.2013.08.009]
28. Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 1996; 23: 29-34 [PMID: 8835896]
29. Freeman HJ. Natural history and clinical behavior of Crohn' s disease extending beyond two decades. J Clin Gastroenterol 2003; 37: 216-219 [PMID: 12960719]
30. Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology 2007; 133: 1670-1689 [PMID: 17983810]
31. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8: 244-250 [PMID: 12131607]
32. Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, El Yafi F, Colombel JF, Belaiche J. Early development of stricturing or penetrating pattern in Crohn' s disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 2003; 52: 552-557 [PMID: 12631668]
33. Smith BR, Arnott ID, Drummond HE, Nimmo ER, Satsangi J. Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease. Inflamm Bowel Dis 2004; 10: 521-528 [PMID: 15472511]
34. Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, Ochsenkühn T, Orchard T, Rogler G, Louis E, Kupcinskas L, Mantzaris G, Travis S, Stange E. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis 2010; 4: 7-27 [PMID: 21122488 DOI: 10.1016/j.crohns.2009.12.003]
35. Price AB . Overlap in the spectrum of non-specific inflammatory bowel disease - 'colitis indeterminate'. J Clin Pathol 1978; 31: 567-577 [PMID: 670413]
36. Martland GT, Shepherd NA. Indeterminate colitis: definition, diagnosis, implications and a plea for nosological sanity. Histopathology 2007; 50: 83-96 [PMID: 17204023]
37. Stewénius J, Adnerhill I, Ekelund GR, Florén CH, Fork FT, Janzon L, Lindström C, Ogren M. Risk of relapse in new cases of ulcerative colitis and indeterminate colitis. Dis Colon Rectum 1996; 39: 1019-1025 [PMID: 8797653]
38. Stewénius J, Adnerhill I, Anderson H, Ekelund GR, Florén CH, Fork FT, Janzon L, Lindström C, Ogren M. Incidence of colorectal cancer and all cause mortality in non-selected patients with ulcerative colitis and indeterminate colitis in Malmö, Sweden. Int J Colorectal Dis 1995; 10: 117-122 [PMID: 7636371]
39. Prideaux L, De Cruz P, Ng SC, Kamm MA. Serological antibodies in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis 2012; 18: 1340-1355 [PMID: 22069240 DOI: 10.1002/ibd.21903]
40. Tyler AD, Milgrom R, Stempak JM, Xu W, Brumell JH, Muise AM, Sehgal R, Cohen Z, Koltun W, Shen B, Silverberg MS. The NOD2insC polymorphism is associated with worse outcome following ileal pouch-anal anastomosis for ulcerative colitis. Gut 2013; 62: 1433-1439 [PMID: 22879519 DOI: 10.1136/gutjnl-2011-301957]
41. Joossens S, Reinisch W, Vermeire S, Sendid B, Poulain D, Peeters M, Geboes K, Bossuyt X, Vandewalle P, Oberhuber G, Vogelsang H, Rutgeerts P, Colombel JF. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology 2002; 122: 1242-1247 [PMID: 11984510]
42. Tremaine WJ . Is indeterminate colitis determinable? Curr Gastroenterol Rep 2012; 14: 162-165 [PMID: 22314810]
43. Meucci G. What is the incidence, prevalence, and natural history of indeterminate colitis? Inflamm Bowel Dis 2008; 14 Suppl 2: S159-S160 [PMID: 18816765 DOI: 10.1002/ibd.20594]
44. Prenzel F, Uhlig HH. Frequency of indeterminate colitis in children and adults with IBD - a metaanalysis. J Crohns Colitis 2009; 3: 277-281 [PMID: 21172287 DOI: 10.1016/j.crohns.2009.07.001]
45. Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, Glickman JN, Gold BD, Griffiths AM, Jevon GP, Higuchi LM, Hyams JS, Kirschner BS, Kugathasan S, Baldassano RN, Russo PA. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn' s and Colitis Foundation of America. J Pediatr Gastroenterol Nutr 2007; 44: 653-674 [PMID: 17460505]
46. Carvalho RS, Abadom V, Dilworth HP, Thompson R, Oliva-Hemker M, Cuffari C. Indeterminate colitis: a significant subgroup of pediatric IBD. Inflamm Bowel Dis 2006; 12: 258-262 [PMID: 16633047]
47. Tremaine WJ . Review article: Indeterminate colitis - definition, diagnosis and management. Aliment Pharmacol Ther 2007; 25: 13-17 [PMID: 17229217]
48. Orlando A, Guglielmi FW, Cottone M, Orlando E, Romano C, Sinagra E. Clinical implications of mucosal healing in the management of patients with inflammatory bowel disease. Dig Liver Dis 2013; 45: 986-991 [PMID: 23993738 DOI: 10.1016/j.dld.2013.07.005]
49. Peyrin-Biroulet L, Ferrante M, Magro F, Campbell S, Franchimont D, Fidder H, Strid H, Ardizzone S, Veereman-Wauters G, Chevaux JB, Allez M, Danese S, Sturm A. Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease. J Crohns Colitis 2011; 5: 477-483 [PMID: 21939925 DOI: 10.1016/j.crohns.2011.06.009]
50. Rutgeerts P, Van Assche G, Sandborn WJ, Wolf DC, Geboes K, Colombel JF, Reinisch W, Kumar A, Lazar A, Camez A, Lomax KG, Pollack PF, D'Haens G. Adalimumab induces and maintains mucosal healing in patients with Crohn' s disease: data from the EXTEND trial. Gastroenterology 2012; 142: 1102-1111.e2 [PMID: 22326435 DOI: 10.1053/j.gastro.2012.01.035]
51. Allen PB, Peyrin-Biroulet L. Moving towards disease modification in inflammatory bowel disease therapy. Curr Opin Gastroenterol 2013; 29: 397-404 [PMID: 23695427 DOI: 10.1097/MOG.0b013e3283622914]
52. Bouguen G, Levesque BG, Feagan BG, Kavanaugh A, Peyrin-Biroulet L, Colombel JF, Hanauer SB, Sandborn WJ. Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease. Clin Gastroenterol Hepatol 2013; Epub ahead of print [PMID: 24036054 DOI: 10.1016/j.cgh.2013.09.006]
53. Tontini GE, Bisschops R, Neumann H. Endoscopic scoring systems for inflammatory bowel disease: pros and cons. Expert Rev Gastroenterol Hepatol 2014; 8: 543-554 [PMID: 24650249 DOI: 10.1586/17474124.2014.899899]
54. Neurath MF, Travis SP. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut 2012; 61: 1619-1635 [PMID: 22842618]
55. Scribano ML, Prantera C. Antibiotics and inflammatory bowel diseases. Dig Dis 2013; 31: 379-384 [PMID: 24246992 DOI: 10.1159/000354704]
56. Lissner D, Siegmund B. Ulcerative colitis: current and future treatment strategies. Dig Dis 2013; 31: 91-94 [PMID: 23797129 DOI: 10.1159/000347194]
57. Vermeire S, Ferrante M, Rutgeerts P. Recent advances: Personalised use of current Crohn's disease therapeutic options. Gut 2013; 62: 1511-1515 [PMID: 24037876 DOI: 10.1136/gutjnl-2012-303958]
58. Gisbert JP, Chaparro M, Gomollón F. Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease. World J Gastroenterol 2011; 17: 3467-3478 [PMID: 21941413 DOI: 10.3748/wjg.v17.i30.3467]
59. Lim WC, Hanauer S. Aminosalicylates for induction of remission or response in Crohn's disease. Cochrane Database Syst Rev 2010; (12): CD008870 [PMID: 21154400 DOI: 10.1002/14651858.CD008870]
60. Saibeni S, Bollani S, Losco A, Michielan A, Sostegni R, Devani M, Lupinacci G, Pirola L, Cucino C, Meucci G, Basilisco G, D'Incà R, Bruno S. The use of methotrexate for treatment of inflammatory bowel disease in clinical practice. Dig Liver Dis 2012; 44: 123-127 [PMID: 22051323 DOI: 10.1016/j.dld.2011.09.015]
61. Willot S, Noble A, Deslandres C. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center. Inflamm Bowel Dis 2011; 17: 2521-2526 [PMID: 21337668 DOI: 10.1002/ibd.21653]
62. McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG. Methotrexate for induction of remission in refractory Crohn' s disease. Cochrane Database Syst Rev 2012; 12: CD003459 [PMID: 23235598 DOI: 10.1002/14651858.CD003459.pub3]
63. Laharie D, Reffet A, Belleannée G, Chabrun E, Subtil C, Razaire S, Capdepont M, de Lédinghen V. Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab. Aliment Pharmacol Ther 2011; 33: 714-721 [PMID: 21235604 DOI: 10.1111/j.1365-2036.2010.04569.x]
64. Feagan BG, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Koval J, Wong CJ, Hopkins M, Hanauer SB, McDonald JW. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med 2000; 342: 1627-1632 [PMID: 10833208]
65. Cominelli F . Inhibition of leukocyte trafficking in inflammatory bowel disease. N Engl J Med 2013; 369: 775-776 [PMID: 23964940 DOI: 10.1056/NEJMe1307415]
66. Monteleone G, Caruso R, Pallone F. Targets for new immunomodulation strategies in inflammatory bowel disease. Autoimmun Rev 2014; 13: 11-14 [PMID: 23774108 DOI: 10.1016/j.autrev.2013.06.003]
67. Günther C, Neumann H, Neurath MF, Becker C. Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium. Gut 2013; 62: 1062-1071 [PMID: 22689519 DOI: 10.1136/gutjnl-2011-301364]
68. Leiman DA, Lichtenstein GR. Therapy of inflammatory bowel disease: what to expect in the next decade. Curr Opin Gastroenterol 2014; 30: 385-390 [PMID: 24902037 DOI: 10.1097/MOG.0000000000000077]
69. Khanna R, Feagan BG. Ustekinumab for the treatment of Crohn's disease. Immunotherapy 2013; 5: 803-815 [PMID: 23902548 DOI: 10.2217/imt.13.81]
70. Lobatón T, Vermeire S, Van Assche G, Rutgeerts P. Review article: anti-adhesion therapies for inflammatory bowel disease. Aliment Pharmacol Ther 2014; 39: 579-594 [PMID: 24479980 DOI: 10.1111/apt.12639]
71. Mozaffari S, Nikfar S, Abdolghaffari AH, Abdollahi M. New biologic therapeutics for ulcerative colitis and Crohn' s disease. Expert Opin Biol Ther 2014; 14: 583-600 [PMID: 24502344 DOI: 10.1517/14712598.2014.885945]
72. Dave M, Purohit T, Razonable R, Loftus EV. Opportunistic infections due to inflammatory bowel disease therapy. Inflamm Bowel Dis 2014; 20: 196-212 [PMID: 24051931 DOI: 10.1097/MIB.0b013e3182a827d2]
73. Lichtenstein GR, Abreu MT, Cohen R, Tremaine W; American Gastroenterological Association. American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 2006; 130: 935-939 [PMID: 16530531]
74. Mason M, Siegel CA. Do inflammatory bowel disease therapies cause cancer? Inflamm Bowel Dis 2013; 19: 1306-1321 [PMID: 23470503 DOI: 10.1097/MIB.0b013e3182807618]
75. Beaugerie L. Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented? Dig Dis 2012; 30: 415-419 [PMID: 22796808 DOI: 10.1159/000338144]
76. Magro F, Peyrin-Biroulet L, Sokol H, Aldeger X, Costa A, Higgins PD, Joyce JC, Katsanos KH, Lopez A, de Xaxars TM, Toader E, Beaugerie L. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III). J Crohns Colitis 2014; 8: 31-44 [PMID: 23721759 DOI: 10.1016/j.crohns.2013.04.006]
77. Deepak P, Sifuentes H, Sherid M, Stobaugh D, Sadozai Y, Ehrenpreis ED. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factoralpha (TNF-α) inhibitors: results of the REFURBISH study. Am J Gastroenterol 2013; 108: 99-105 [PMID: 23032984 DOI: 10.1038/ajg.2012.334]
78. Marcello PW, Roberts PL, Schoetz DJ, Coller JA, Murray JJ, Veidenheimer MC. Long-term results of the ileoanal pouch procedure. Arch Surg 1993; 128: 500-503; discussion 503-504 [PMID: 8489382]
79. Murrell ZA, Melmed GY, Ippoliti A, Vasiliauskas EA, Dubinsky M, Targan SR, Fleshner PR. A prospective evaluation of the long-term outcome of ileal pouchanal anastomosis in patients with inflammatory bowel disease-unclassified and indeterminate colitis. Dis Colon Rectum 2009; 52: 872-878 [PMID: 19502850 DOI: 10.1007/DCR.0b013e31819f5d4c]
80. Fazio VW, Kiran RP, Remzi FH, Coffey JC, Heneghan HM, Kirat HT, Manilich E, Shen B, Martin ST. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg 2013; 257: 679-685 [PMID: 23299522 DOI: 10.1097/SLA.0b013e31827d99a2]
81. Shen B. Crohn's disease of the ileal pouch: reality, diagnosis, and management. Inflamm Bowel Dis 2009; 15: 284-294 [PMID: 18816633 DOI: 10.1002/ibd.20661]
82. Gawad KA, Wenske S, von Schrenck T, Izbicki JR. Ileoanalpouch reconstruction does not impair sphincter function or quality of life. Hepatogastroenterology 2007; 54: 1477-1482 [PMID: 17708280]
83. Arseneau KO, Sultan S, Provenzale DT, Onken J, Bickston SJ, Foley E, Connors AF, Cominelli F. Do patient preferences influence decisions on treatment for patients with steroidrefractory ulcerative colitis? Clin Gastroenterol Hepatol 2006; 4: 1135-1142 [PMID: 16829206]
84. Berndtsson I, Lindholm E, Oresland T, Börjesson L. Longterm outcome after ileal pouch-anal anastomosis: function and health-related quality of life. Dis Colon Rectum 2007; 50: 1545-1552 [PMID: 17762968]
85. Heikens JT, de Vries J, van Laarhoven CJ. Quality of life, health-related quality of life and health status in patients having restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis: a systematic review. Colorectal Dis 2012; 14: 536-544 [PMID: 21176062 DOI: 10.1111/j.1463-1318.2010.02538.x]
86. Carmon E, Keidar A, Ravid A, Goldman G, Rabau M. The correlation between quality of life and functional outcome in ulcerative colitis patients after proctocolectomy ileal pouch anal anastomosis. Colorectal Dis 2003; 5: 228-232 [PMID: 12780883]
87. Fazio VW, O'Riordain MG, Lavery IC, Church JM, Lau P, Strong SA, Hull T. Long-term functional outcome and quality of life after stapled restorative proctocolectomy. Ann Surg 1999; 230: 575-584; discussion 584-586 [PMID: 10522727]
88. Thirlby RC, Sobrino MA, Randall JB. The long-term benefit of surgery on health-related quality of life in patients with inflammatory bowel disease. Arch Surg 2001; 136: 521-527 [PMID: 11343542]
89. Brown CJ, Maclean AR, Cohen Z, Macrae HM, O'Connor BI, McLeod RS. Crohn's disease and indeterminate colitis and the ileal pouch-anal anastomosis: outcomes and patterns of failure. Dis Colon Rectum 2005; 48: 1542-1549 [PMID: 15937625]
90. Yu CS, Pemberton JH, Larson D. Ileal pouch-anal anastomosis in patients with indeterminate colitis: longterm results. Dis Colon Rectum 2000; 43: 1487-1496 [PMID: 11089581]
91. Stewénius I, Ekelund GR, Florén CH, Fork FT, Janzon L, Lindström C, Ogren M. Operations in unselected patients with ulcerative colitis and indeterminate colitis. A longterm follow-up study. Eur J Surg 1996; 162: 131-137 [PMID: 8639726]
92. McIntyre PB, Pemberton JH, Wolff BG, Dozois RR, Beart RW. Indeterminate colitis. Long-term outcome in patients after ileal pouch-anal anastomosis. Dis Colon Rectum 1995; 38: 51-54 [PMID: 7813345]
93. Atkinson KG, Owen DA, Wankling G. Restorative proctocolectomy and indeterminate colitis. Am J Surg 1994; 167: 516-518 [PMID: 8185040]
94. Hartley JE, Fazio VW, Remzi FH, Lavery IC, Church JM, Strong SA, Hull TL, Senagore AJ, Delaney CP. Analysis of the outcome of ileal pouch-anal anastomosis in patients with Crohn's disease. Dis Colon Rectum 2004; 47: 1808-1815 [PMID: 15622572]
95. Braveman JM, Schoetz DJ, Marcello PW, Roberts PL, Coller JA, Murray JJ, Rusin LC. The fate of the ileal pouch in patients developing Crohn's disease. Dis Colon Rectum 2004; 47: 1613-1619 [PMID: 15540289]
96. Tekkis PP, Heriot AG, Smith O, Smith JJ, Windsor AC, Nicholls RJ. Long-term outcomes of restorative proctocolectomy for Crohn's disease and indeterminate colitis. Colorectal Dis 2005; 7: 218-223 [PMID: 15859957]
97. Connelly TM, Koltun WA. The surgical treatment of inflammatory bowel disease-associated dysplasia. Expert Rev Gastroenterol Hepatol 2013; 7: 307-321; quiz 322 [PMID: 23639089 DOI: 10.1586/egh.13.17]
98. Deutsch AA, McLeod RS, Cullen J, Cohen Z. Results of the pelvic-pouch procedure in patients with Crohn's disease. Dis Colon Rectum 1991; 34: 475-477 [PMID: 2036927]
99. Hyman NH, Fazio VW, Tuckson WB, Lavery IC. Consequences of ileal pouch-anal anastomosis for Crohn's colitis. Dis Colon Rectum 1991; 34: 653-657 [PMID: 1855421]
100. Moss AC, Cheifetz AS. How often is a diagnosis of ulcerative colitis changed to Crohn's disease and vice versa? Inflamm Bowel Dis 2008; 14 Suppl 2: S155-S156 [PMID: 18816774 DOI: 10.1002/ibd.20593]
101. Melmed GY, Fleshner PR, Bardakcioglu O, Ippoliti A, Vasiliauskas EA, Papadakis KA, Dubinsky M, Landers C, Rotter JI, Targan SR. Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2008; 51: 100-108 [PMID: 18085333]
102. Wolkomir AF, Luchtefeld MA. Surgery for symptomatic hemorrhoids and anal fissures in Crohn's disease. Dis Colon Rectum 1993; 36: 545-547 [PMID: 8500370]
103. Jeffery PJ, Parks AG, Ritchie JK. Treatment of haemorrhoids in patients with inflammatory bowel disease. Lancet 1977; 1: 1084-1085 [PMID: 68184]
104. D'Ugo S, Franceschilli L, Cadeddu F, Leccesi L, Blanco Gdel V, Calabrese E, Milito G, Di Lorenzo N, Gaspari AL, Sileri P. Medical and surgical treatment of haemorrhoids and anal fissure in Crohn's disease: a critical appraisal. BMC Gastroenterol 2013; 13: 47 [PMID: 23496835 DOI: 10.1186/1471-230X-13-47]
105. Peyrin-Biroulet L, Loftus EV, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Perianal Crohn's disease findings other than fistulas in a population-based cohort. Inflamm Bowel Dis 2012; 18: 43-48 [PMID: 21351216 DOI: 10.1002/ibd.21674]
106. Bouguen G, Siproudhis L, Bretagne JF, Bigard MA, Peyrin-Biroulet L. Nonfistulizing perianal Crohn's disease: clinical features, epidemiology, and treatment. Inflamm Bowel Dis 2010; 16: 1431-1442 [PMID: 20310013 DOI: 10.1002/ibd.21261]
107. American Gastroenterological Association Clinical Practice Committee . American Gastroenterological Association medical position statement: perianal Crohn's disease. Gastroenterology 2003; 125: 1503-1507 [PMID: 14598267]
108. Daperno M, Castiglione F, de Ridder L, Dotan I, Färkkilä M, Florholmen J, Fraser G, Fries W, Hebuterne X, Lakatos PL, Panés J, Rimola J, Louis E. Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease. J Crohns Colitis 2011; 5: 484-498 [PMID: 21939926 DOI: 10.1016/j.crohns.2011.07.003]
109. Armuzzi A, Van Assche G, Reinisch W, Pineton de Chambrun G, Griffiths A, Sladek M, Preiss JC, Lukas M, D' Haens G. Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease. J Crohns Colitis 2012; 6: 492-502 [PMID: 22406343 DOI: 10.1016/j.crohns.2011.12.016]
110. Papi C, Fascì-Spurio F, Rogai F, Settesoldi A, Margagnoni G, Annese V. Mucosal healing in inflammatory bowel disease: treatment efficacy and predictive factors. Dig Liver Dis 2013; 45: 978-985 [PMID: 24018244 DOI: 10.1016/j.dld.2013.07.006]
111. Mazzuoli S, Guglielmi FW, Antonelli E, Salemme M, Bassotti G, Villanacci V. Definition and evaluation of mucosal healing in clinical practice. Dig Liver Dis 2013; 45: 969-977 [PMID: 23932331 DOI: 10.1016/j.dld.2013.06.010]
112. Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, Reinisch W, Colombel JF, Vermeire S, Travis S, Lindsay JO, Van Assche G. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis 2012; 6: 965-990 [PMID: 23040452 DOI: 10.1016/ j.crohns.2012.09.003]
113. Lennard-Jones JE, Shivananda S. Clinical uniformity of inflammatory bowel disease a presentation and during the first year of disease in the north and south of Europe. ECIBD Study Group. Eur J Gastroenterol Hepatol 1997; 9: 353-359 [PMID: 9160197]
114. Sands BE. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 2004; 126: 1518-1532 [PMID: 15168364]
115. Schwartz DA, Loftus EV, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122: 875-880 [PMID: 11910338]
116. Bonheur JL, Braunstein J, Korelitz BI, Panagopoulos G. Anal skin tags in inflammatory bowel disease: new observations and a clinical review. Inflamm Bowel Dis 2008; 14: 1236-1239 [PMID: 18452201 DOI: 10.1002/ibd.20458]
117. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005; 129: 827-836 [PMID: 16143122]
118. Williams H, Walker D, Orchard TR. Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep 2008; 10: 597-605 [PMID: 19006617]
119. Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2011; 7: 235-241 [PMID: 21857821]
120. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001; 96: 1116-1122 [PMID: 11316157]
121. Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F. Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol 2005; 20: 1691-1695 [PMID: 16246187]
122. Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, Lakatos PL. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol 2003; 9: 2300-2307 [PMID: 14562397]
123. Tavarela Veloso F . Review article: skin complications associated with inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20 Suppl 4: 50-53 [PMID: 15352894]
124. Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, Rogler G, Schoepfer AM. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 2011; 106: 110-119 [PMID: 20808297]
125. Orchard TR, Chua CN, Ahmad T, Cheng H, Welsh KI, Jewell DP. Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology 2002; 123: 714-718 [PMID: 12198697]
126. Boonstra K, Weersma RK, van Erpecum KJ, Rauws EA, Spanier BW, Poen AC, van Nieuwkerk KM, Drenth JP, Witteman BJ, Tuynman HA, Naber AH, Kingma PJ, van Buuren HR, van Hoek B, Vleggaar FP, van Geloven N, Beuers U, Ponsioen CY. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 2013; 58: 2045-2055 [PMID: 23775876 DOI: 10.1002/hep.26565]
127. Mintz R, Feller ER, Bahr RL, Shah SA. Ocular manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2004; 10: 135-139 [PMID: 15168814]
128. Targownik LE, Bernstein CN, Nugent Z, Leslie WD. Inflammatory bowel disease has a small effect on bone mineral density and risk for osteoporosis. Clin Gastroenterol Hepatol 2013; 11: 278-285 [PMID: 23103821 DOI: 10.1016/j.cgh.2012.10.022]
129. Walldorf J, Krummenerl A, Engler K, Busch J, Dollinger MM, Seufferlein T, Albert JG. Health care for osteoporosis in inflammatory bowel disease: unmet needs in care of male patients? J Crohns Colitis 2013; 7: 901-907 [PMID: 23333038 DOI: 10.1016/j.crohns.2012.12.008]
130. Loftus EV, Crowson CS, Sandborn WJ, Tremaine WJ, O' Fallon WM, Melton LJ. Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota. Gastroenterology 2002; 123: 468-475 [PMID: 12145800]
131. Loftus EV, Achenbach SJ, Sandborn WJ, Tremaine WJ, Oberg AL, Melton LJ. Risk of fracture in ulcerative colitis: a population-based study from Olmsted County, Minnesota. Clin Gastroenterol Hepatol 2003; 1: 465-473 [PMID: 15017646]
132. Lankarani KB, Sivandzadeh GR, Hassanpour S. Oral manifestation in inflammatory bowel disease: a review. World J Gastroenterol 2013; 19: 8571-8579 [PMID: 24379574 DOI: 10.3748/wjg.v19.i46.8571]
133. Cattaneo M, Vecchi M. Inflammatory bowel disease and the risk of thrombosis. Gastroenterology 1999; 117: 280-281 [PMID: 10428611]
134. Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008; 103: 2272-2280 [PMID: 18684186 DOI: 10.1111/j.1572-0241.2008.02052.x]
135. Novacek G, Weltermann A, Sobala A, Tilg H, Petritsch W, Reinisch W, Mayer A, Haas T, Kaser A, Feichtenschlager T, Fuchssteiner H, Knoflach P, Vogelsang H, Miehsler W, Platzer R, Tillinger W, Jaritz B, Schmid A, Blaha B, Dejaco C, Eichinger S. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology 2010; 139: 779-787, 787.e1 [PMID: 20546736 DOI: 10.1053/j.gastro.2010.05.026]
136. Spina L, Saibeni S, Battaglioli T, Peyvandi F, de Franchis R, Vecchi M. Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia. Am J Gastroenterol 2005; 100: 2036-2041 [PMID: 16128949]
137. Casella G, Tontini GE, Bassotti G, Pastorelli L, Villanacci V, Spina L, Baldini V, Vecchi M. Neurological disorders and inflammatory bowel diseases. World J Gastroenterol 2014; 20: 8764-8782 [PMID: 25083051 DOI: 10.3748/wjg.v20.i27.8764]
138. Agarwal A, Andrews JM. Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapy. Aliment Pharmacol Ther 2013; 38: 563-572 [PMID: 23914999 DOI: 10.1111/apt.12431]
139. Lu DG, Ji XQ, Liu X, Li HJ, Zhang CQ. Pulmonary manifestations of Crohn's disease. World J Gastroenterol 2014; 20: 133-141 [PMID: 24415866 DOI: 10.3748/wjg.v20.i1.133]
140. Lashner BA, Evans AA, Kirsner JB, Hanauer SB. Prevalence and incidence of inflammatory bowel disease in family members. Gastroenterology 1986; 91: 1396-1400 [PMID: 3770366]
141. Sachar DB. Crohn's disease: a family affair. Gastroenterology 1996; 111: 813-815 [PMID: 8780588]
142. Reynisdottir I, Gudbjartsson DF, Johannsson JH, Manolescu I, Kristjansson K, Stefansson K, Gulcher J, Bjornsson S. A genetic contribution to inflammatory bowel disease in Iceland: a genealogic approach. Clin Gastroenterol Hepatol 2004; 2: 806-812 [PMID: 15354281]
143. Russell RK, Satsangi J. IBD: a family affair. Best Pract Res Clin Gastroenterol 2004; 18: 525-539 [PMID: 15157825]
144. Annese V, Andreoli A, Astegiano M, Campieri M, Caprilli R, Cucchiara S, D'Incà R, Giaccari S, Iaquinto G, Lombardi G, Napolitano G, Pera A, Riegler G, Valpiani D, Andriulli A. Clinical features in familial cases of Crohn's disease and ulcerative colitis in Italy: a GISC study. Italian Study Group for the Disease of Colon and Rectum. Am J Gastroenterol 2001; 96: 2939-2945 [PMID: 11693330]
145. Meucci G, Vecchi M, Torgano G, Arrigoni M, Prada A, Rocca F, Curzio M, Pera A, de Franchis R. Familial aggregation of inflammatory bowel disease in northern Italy: a multicenter study. The Gruppo di Studio per le Malattie Infiammatorie Intestinali (IBD Study Group). Gastroenterology 1992; 103: 514-519 [PMID: 1634069]
146. Satsangi J, Grootscholten C, Holt H, Jewell DP. Clinical patterns of familial inflammatory bowel disease. Gut 1996; 38: 738-741 [PMID: 8707121]
147. Lewis JD . The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology 2011; 140: 1817-1826.e2 [PMID: 21530748 DOI: 10.1053/j.gastro.2010.11.058]
148. Iskandar HN, Ciorba MA. Biomarkers in inflammatory bowel disease: current practices and recent advances. Transl Res 2012; 159: 313-325 [PMID: 22424434 DOI: 10.1016/j.trsl.2012.01.001]
149. Jones J, Loftus EV, Panaccione R, Chen LS, Peterson S, McConnell J, Baudhuin L, Hanson K, Feagan BG, Harmsen SW, Zinsmeister AR, Helou E, Sandborn WJ. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol 2008; 6: 1218-1224 [PMID: 18799360 DOI: 10.1016/j.cgh.2008.06.010]
150. Solem CA, Loftus EV, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 707-712 [PMID: 16043984]
151. Colombel JF, Solem CA, Sandborn WJ, Booya F, Loftus EV, Harmsen WS, Zinsmeister AR, Bodily KD, Fletcher JG. Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut 2006; 55: 1561-1567 [PMID: 16648154]
152. Gross V, Andus T, Caesar I, Roth M, Schölmerich J. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology 1992; 102: 514-519 [PMID: 1370661]
153. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 2006; 55: 426-431 [PMID: 16474109]
154. Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut 2008; 57: 1518-1523 [PMID: 18566104 DOI: 10.1136/gut.2007.146357]
155. Prantera C, Davoli M, Lorenzetti R, Pallone F, Marcheggiano A, Iannoni C, Mariotti S. Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the most. J Clin Gastroenterol 1988; 10: 41-45 [PMID: 3356884]
156. Rodgers AD, Cummins AG. CRP correlates with clinical score in ulcerative colitis but not in Crohn's disease. Dig Dis Sci 2007; 52: 2063-2068 [PMID: 17436102]
157. D'Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, Geens P, Iwens D, Aerden I, Van Assche G, Van Olmen G, Rutgeerts P. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 2218-2224 [PMID: 22344983 DOI: 10.1002/ibd.22917]
158. Nancey S, Boschetti G, Moussata D, Cotte E, Peyras J, Cuerq C, Haybrard J, Charlois AL, Mialon A, Chauvenet M, Stroeymeyt K, Kaiserlian D, Drai J, Flourié B. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases. Inflamm Bowel Dis 2013; 19: 1043-1052 [PMID: 23511035 DOI: 10.1097/MIB.0b013e3182807577]
159. van de Logt F, Day AS. S100A12: a noninvasive marker of inflammation in inflammatory bowel disease. J Dig Dis 2013; 14: 62-67 [PMID: 23146044 DOI: 10.1111/1751-2980.12012]
160. Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMNelastase, CRP, and clinical indices. Am J Gastroenterol 2008; 103: 162-169 [PMID: 17916108]
161. Sipponen T, Kärkkäinen P, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Färkkilä M. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings. Aliment Pharmacol Ther 2008; 28: 1221-1229 [PMID: 18752630 DOI: 10.1111/j.1365-2036.2008.03835.x]
162. Sipponen T, Haapamäki J, Savilahti E, Alfthan H, Hämäläinen E, Rautiainen H, Koskenpato J, Nuutinen H, Färkkilä M. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy. Scand J Gastroenterol 2012; 47: 778-784 [PMID: 22519419 DOI: 10.3109/00365521.2012.677953]
163. Roseth AG, Aadland E, Jahnsen J, Raknerud N. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997; 58: 176-180 [PMID: 9144308]
164. Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, Shoenfeld Y. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005; 54: 1232-1236 [PMID: 16099791]
165. van Schaik FD, Oldenburg B, Hart AR, Siersema PD, Lindgren S, Grip O, Teucher B, Kaaks R, Bergmann MM, Boeing H, Carbonnel F, Jantchou P, Boutron-Ruault MC, Tjonneland A, Olsen A, Crowe FL, Peeters PH, van Oijen MG, Bueno-de-Mesquita HB. Serological markers predict inflammatory bowel disease years before the diagnosis. Gut 2013; 62: 683-688 [PMID: 22842615 DOI: 10.1136/gutjnl-2012-302717]
166. Vecchi M, Spina L, Cavallaro F, Pastorelli L. Do antibodies have a role in IBD pathogenesis? Inflamm Bowel Dis 2008; 14 Suppl 2: S95-S96 [PMID: 18816674 DOI: 10.1002/ibd.20699]
167. Dotan I, Plevy SE. NOD2 and pouch complications in UC patients: old-world clinical dogmas give way to biological definitions. Gut 2013; 62: 1390-1391 [PMID: 23292664 DOI: 10.1136/gutjnl-2012-303188]
168. De Vroey B, Gower-Rousseau C, Colombel JF. Exploring life before IBD. Gut 2013; 62: 662-663 [PMID: 22936675 DOI: 10.1136/gutjnl-2012-303245]
169. Annese V, Andreoli A, Andriulli A, Dinca R, Gionchetti P, Latiano A, Lombardi G, Piepoli A, Poulain D, Sendid B, Colombel JF. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study. Am J Gastroenterol 2001; 96: 2407-2412 [PMID: 11513182]
170. Papp M, Altorjay I, Dotan N, Palatka K, Foldi I, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Norman GL, Szamosi T, Papp J, Lakatos PL. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Am J Gastroenterol 2008; 103: 665-681 [PMID: 18047543]
171. Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, Lerner A, Weishauss O, Spector L, Shtevi A, Altstock RT, Dotan N, Halpern Z. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 2006; 131: 366-378 [PMID: 16890590]
172. Vermeire S, Joossens S, Peeters M, Monsuur F, Marien G, Bossuyt X, Groenen P, Vlietinck R, Rutgeerts P. Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology 2001; 120: 827-833 [PMID: 11231936]
173. Ruemmele FM, Targan SR, Levy G, Dubinsky M, Braun J, Seidman EG. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998; 115: 822-829 [PMID: 9753483]
174. Bouguen G, Peyrin-Biroulet L. Surgery for adult Crohn' s disease: what is the actual risk? Gut 2011; 60: 1178-1181 [PMID: 21610273 DOI: 10.1136/gut.2010.234617]
175. Vandewalle-El Khoury P, Colombel JF, Joossens S, Standaert-Vitse A, Collot M, Halfvarson J, Ayadi A, Landers CJ, Vermeire S, Rutgeerts P, Targan SR, Chamaillard M, Mallet JM, Sendid B, Poulain D. Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction. Am J Gastroenterol 2008; 103: 949-957 [PMID: 18047546]
176. Lakatos PL, Papp M, Rieder F. Serologic antiglycan antibodies in inflammatory bowel disease. Am J Gastroenterol 2011; 106: 406-412 [PMID: 21245832 DOI: 10.1038/ajg.2010.505]
177. Bohr J, Tysk C, Yang P, Danielsson D, Järnerot G. Autoantibodies and immunoglobulins in collagenous colitis. Gut 1996; 39: 73-76 [PMID: 8881813]
178. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 1991; 100: 1590-1596 [PMID: 2019365]
179. Reese GE, Constantinides VA, Simillis C, Darzi AW, Orchard TR, Fazio VW, Tekkis PP. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol 2006; 101: 2410-2422 [PMID: 16952282]
180. Vasiliauskas EA, Plevy SE, Landers CJ, Binder SW, Ferguson DM, Yang H, Rotter JI, Vidrich A, Targan SR. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology 1996; 110: 1810-1819 [PMID: 8964407]
181. Saibeni S, Folli C, de Franchis R, Borsi G, Vecchi M. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases. Dig Liver Dis 2003; 35: 862-868 [PMID: 14703881]
182. Benor S, Russell GH, Silver M, Israel EJ, Yuan Q, Winter HS. Shortcomings of the inflammatory bowel disease Serology 7 panel. Pediatrics 2010; 125: 1230-1236 [PMID: 20439597 DOI: 10.1542/peds.2009-1936]
183. Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol 2004; 99: 2235-2241 [PMID: 15555007]
184. Ferrante M, Henckaerts L, Joossens M, Pierik M, Joossens S, Dotan N, Norman GL, Altstock RT, Van Steen K, Rutgeerts P, Van Assche G, Vermeire S. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 2007; 56: 1394-1403 [PMID: 17456509]
185. Simondi D, Mengozzi G, Betteto S, Bonardi R, Ghignone RP, Fagoonee S, Pellicano R, Sguazzini C, Pagni R, Rizzetto M, Astegiano M. Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease. Inflamm Bowel Dis 2008; 14: 645-651 [PMID: 18240283 DOI: 10.1002/ibd.20368]
186. Seow CH, Stempak JM, Xu W, Lan H, Griffiths AM, Greenberg GR, Steinhart AH, Dotan N, Silverberg MS. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype. Am J Gastroenterol 2009; 104: 1426-1434 [PMID: 19491856 DOI: 10.1038/ajg.2009.79]
187. Rieder F, Schleder S, Wolf A, Dirmeier A, Strauch U, Obermeier F, Lopez R, Spector L, Fire E, Yarden J, Rogler G, Dotan N, Klebl F. Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior. Inflamm Bowel Dis 2010; 16: 263-274 [PMID: 19653286 DOI: 10.1002/ibd.21046]
188. Schoepfer AM, Schaffer T, Mueller S, Flogerzi B, Vassella E, Seibold-Schmid B, Seibold F. Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort. Inflamm Bowel Dis 2009; 15: 1358-1367 [PMID: 19253375 DOI: 10.1002/ibd.20892]
189. Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 2001; 96: 730-734 [PMID: 11280542]
190. Joossens S, Colombel JF, Landers C, Poulain D, Geboes K, Bossuyt X, Targan S, Rutgeerts P, Reinisch W. Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis. Gut 2006; 55: 1667-1669 [PMID: 16687433]
191. Vecchi M, Gionchetti P, Bianchi MB, Belluzzi A, Meucci G, Campieri M, de Franchis R. p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis. Lancet 1994; 344: 886-887 [PMID: 7916418]
192. Sandborn WJ, Loftus EV, Colombel JF, Fleming KA, Seibold F, Homburger HA, Sendid B, Chapman RW, Tremaine WJ, Kaul DK, Wallace J, Harmsen WS, Zinsmeister AR, Targan SR. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 2001; 7: 192-201 [PMID: 11515844]
193. Fleshner P, Ippoliti A, Dubinsky M, Vasiliauskas E, Mei L, Papadakis KA, Rotter JI, Landers C, Targan S. Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouchanal anastomosis. Clin Gastroenterol Hepatol 2008; 6: 561-568 [PMID: 18378498 DOI: 10.1016/j.cgh.2008.01.002]
194. Panes J, Bouhnik Y, Reinisch W, Stoker J, Taylor SA, Baumgart DC, Danese S, Halligan S, Marincek B, Matos C, Peyrin-Biroulet L, Rimola J, Rogler G, van Assche G, Ardizzone S, Ba-Ssalamah A, Bali MA, Bellini D, Biancone L, Castiglione F, Ehehalt R, Grassi R, Kucharzik T, Maccioni F, Maconi G, Magro F, Martín-Comín J, Morana G, Pendsé D, Sebastian S, Signore A, Tolan D, Tielbeek JA, Weishaupt D, Wiarda B, Laghi A. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 2013; 7: 556-585 [PMID: 23583097 DOI: 10.1016/j.crohns.2013.02.020]
195. Tontini GE, Vecchi M, Neurath MF, Neumann H. Advanced endoscopic imaging techniques in Crohn's disease. J Crohns Colitis 2014; 8: 261-269 [PMID: 24080247 DOI: 10.1016/j.crohns.2013.09.004]
196. Bourreille A, Ignjatovic A, Aabakken L, Loftus EV, Eliakim R, Pennazio M, Bouhnik Y, Seidman E, Keuchel M, Albert JG, Ardizzone S, Bar-Meir S, Bisschops R, Despott EJ, Fortun PF, Heuschkel R, Kammermeier J, Leighton JA, Mantzaris GJ, Moussata D, Lo S, Paulsen V, Panés J, Radford-Smith G, Reinisch W, Rondonotti E, Sanders DS, Swoger JM, Yamamoto H, Travis S, Colombel JF, Van Gossum A. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy 2009; 41: 618-637 [PMID: 19588292 DOI: 10.1055/s-0029-1214790]
197. Fraquelli M, Colli A, Casazza G, Paggi S, Colucci A, Massironi S, Duca P, Conte D. Role of US in detection of Crohn disease: meta-analysis. Radiology 2005; 236: 95-101 [PMID: 15987966]
198. Ordás I, Rimola J, García-Bosch O, Rodríguez S, Gallego M, Etchevers MJ, Pellisé M, Feu F, González-Suárez B, Ayuso C, Ricart E, Panés J. Diagnostic accuracy of magnetic resonance colonography for the evaluation of disease activity and severity in ulcerative colitis: a prospective study. Gut 2013; 62: 1566-1572 [PMID: 22936673 DOI: 10.1136/gutjnl-2012-303240]
199. Fiorino G, Bonifacio C, Malesci A, Balzarini L, Danese S. MRI in Crohn's disease - current and future clinical applications. Nat Rev Gastroenterol Hepatol 2012; 9: 23-31 [PMID: 22105109 DOI: 10.1038/nrgastro.2011.214]
200. Ellrichmann M, Wietzke-Braun P, Dhar S, Nikolaus S, Arlt A, Bethge J, Kuehbacher T, Wintermeyer L, Balschun K, Klapper W, Schreiber S, Fritscher-Ravens A. Endoscopic ultrasound of the colon for the differentiation of Crohn' s disease and ulcerative colitis in comparison with healthy controls. Aliment Pharmacol Ther 2014; 39: 823-833 [PMID: 24612000 DOI: 10.1111/apt.12671]
201. Schusselé Filliettaz S, Juillerat P, Burnand B, Arditi C, Windsor A, Beglinger C, Dubois RW, Peytremann-Bridevaux I, Pittet V, Gonvers JJ, Froehlich F, Vader JP. Appropriateness of colonoscopy in Europe (EPAGE II). Chronic diarrhea and known inflammatory bowel disease. Endoscopy 2009; 41: 218-226 [PMID: 19280533 DOI: 10.1055/s-0028-1119627]
202. Shen B, Khan K, Ikenberry SO, Anderson MA, Banerjee S, Baron T, Ben-Menachem T, Cash BD, Fanelli RD, Fisher L, Fukami N, Gan SI, Harrison ME, Jagannath S, Lee Krinsky M, Levy M, Maple JT, Lichtenstein D, Stewart L, Strohmeyer L, Dominitz JA. The role of endoscopy in the management of patients with diarrhea. Gastrointest Endosc 2010; 71: 887-892 [PMID: 20346452 DOI: 10.1016/j.gie.2009.11.025]
203. Pera A, Bellando P, Caldera D, Ponti V, Astegiano M, Barletti C, David E, Arrigoni A, Rocca G, Verme G. Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology 1987; 92: 181-185 [PMID: 3781186]
204. Haskell H, Andrews CW, Reddy SI, Dendrinos K, Farraye FA, Stucchi AF, Becker JM, Odze RD. Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis. Am J Surg Pathol 2005; 29: 1472-1481 [PMID: 16224214]
205. Heuschen UA, Hinz U, Allemeyer EH, Stern J, Lucas M, Autschbach F, Herfarth C, Heuschen G. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology 2001; 120: 841-847 [PMID: 11231938]
206. Bernstein CN, Shanahan F, Anton PA, Weinstein WM. Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. Gastrointest Endosc 1995; 42: 232-237 [PMID: 7498688]
207. D'Haens G, Geboes K, Ponette E, Penninckx F, Rutgeerts P. Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease. Gastroenterology 1997; 112: 1475-1481 [PMID: 9136824]
208. Yang SK, Jung HY, Kang GH, Kim YM, Myung SJ, Shim KN, Hong WS, Min YI. Appendiceal orifice inflammation as a skip lesion in ulcerative colitis: an analysis in relation to medical therapy and disease extent. Gastrointest Endosc 1999; 49: 743-747 [PMID: 10343220]
209. Ladefoged K, Munck LK, Jorgensen F, Engel P. Skip inflammation of the appendiceal orifice: a prospective endoscopic study. Scand J Gastroenterol 2005; 40: 1192-1196 [PMID: 16265776]
210. Loftus EV, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS, Zinsmeister AR, Jewell DA, Sandborn WJ. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005; 54: 91-96 [PMID: 15591511]
211. Glickman JN, Bousvaros A, Farraye FA, Zholudev A, Friedman S, Wang HH, Leichtner AM, Odze RD. Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am J Surg Pathol 2004; 28: 190-197 [PMID: 15043308]
212. Markowitz J, Kahn E, Grancher K, Hyams J, Treem W, Daum F. Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis. Am J Gastroenterol 1993; 88: 2034-2037 [PMID: 8249970]
213. Washington K, Greenson JK, Montgomery E, Shyr Y, Crissinger KD, Polk DB, Barnard J, Lauwers GY. Histopathology of ulcerative colitis in initial rectal biopsy in children. Am J Surg Pathol 2002; 26: 1441-1449 [PMID: 12409720]
214. Levine A, de Bie CI, Turner D, Cucchiara S, Sladek M, Murphy MS, Escher JC. Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis 2013; 19: 370-377 [PMID: 22570259 DOI: 10.1002/ibd.23013]
215. Joo M, Odze RD. Rectal sparing and skip lesions in ulcerative colitis: a comparative study of endoscopic and histologic findings in patients who underwent proctocolectomy. Am J Surg Pathol 2010; 34: 689-696 [PMID: 20410806 DOI: 10.1097/PAS.0b013e3181db84cd]
216. Kim B, Barnett JL, Kleer CG, Appelman HD. Endoscopic and histological patchiness in treated ulcerative colitis. Am J Gastroenterol 1999; 94: 3258-3262 [PMID: 10566726]
217. Kleer CG, Appelman HD. Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time. Am J Surg Pathol 1998; 22: 983-989 [PMID: 9706978]
218. Yamagata M, Mikami T, Tsuruta T, Yokoyama K, Sada M, Kobayashi K, Katsumata T, Koizumi W, Saigenji K, Okayasu I. Submucosal fibrosis and basic-fibroblast growth factor-positive neutrophils correlate with colonic stenosis in cases of ulcerative colitis. Digestion 2011; 84: 12-21 [PMID: 21304240 DOI: 10.1159/000320773]
219. Feakins RM. Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines. J Clin Pathol 2013; 66: 1005-1026 [PMID: 23999270 DOI: 10.1136/jclinpath-2013-201885]
220. Geboes K. What histologic features best differentiate Crohn' s disease from ulcerative colitis? Inflamm Bowel Dis 2008; 14 Suppl 2: S168-S169 [PMID: 18816725 DOI: 10.1002/ibd.20598]
221. Feakins RM . Ulcerative colitis or Crohn's disease? Pitfalls and problems. Histopathology 2014; 64: 317-335 [PMID: 24266813 DOI: 10.1111/his.12263]
222. Shepherd NA. Granulomas in the diagnosis of intestinal Crohn's disease: a myth exploded? Histopathology 2002; 41: 166-168 [PMID: 12147095]
223. Shepherd NA. Pathological mimics of chronic inflammatory bowel disease. J Clin Pathol 1991; 44: 726-733 [PMID: 1918397]
224. Pulimood AB, Amarapurkar DN, Ghoshal U, Phillip M, Pai CG, Reddy DN, Nagi B, Ramakrishna BS. Differentiation of Crohn's disease from intestinal tuberculosis in India in 2010. World J Gastroenterol 2011; 17: 433-443 [PMID: 21274372 DOI: 10.3748/wjg.v17.i4.433]
225. Lamps LW. Infective disorders of the gastrointestinal tract. Histopathology 2007; 50: 55-63 [PMID: 17204021]
226. Khor TS, Fujita H, Nagata K, Shimizu M, Lauwers GY. Biopsy interpretation of colonic biopsies when inflammatory bowel disease is excluded. J Gastroenterol 2012; 47: 226-248 [PMID: 22322659 DOI: 10.1007/s00535-012-0539-6]
227. Day DW, Mandal BK, Morson BC. The rectal biopsy appearances in Salmonella colitis. Histopathology 1978; 2: 117-131 [PMID: 669591]
228. Price AB, Jewkes J, Sanderson PJ. Acute diarrhoea: Campylobacter colitis and the role of rectal biopsy. J Clin Pathol 1979; 32: 990-997 [PMID: 521501]
229. El-Maraghi NR, Mair NS. The histopathology of enteric infection with Yersinia pseudotuberculosis. Am J Clin Pathol 1979; 71: 631-639 [PMID: 377942]
230. Surawicz CM, Haggitt RC, Husseman M, McFarland LV. Mucosal biopsy diagnosis of colitis: acute self-limited colitis and idiopathic inflammatory bowel disease. Gastroenterology 1994; 107: 755-763 [PMID: 8076762]
231. De Hertogh G, Geboes K. Crohn's disease and infections: a complex relationship. MedGenMed 2004; 6: 14 [PMID: 15520637]
232. Shepherd NA. Diverticular disease and chronic idiopathic inflammatory bowel disease: associations and masquerades. Gut 1996; 38: 801-802 [PMID: 8984012]
233. Makapugay LM, Dean PJ. Diverticular disease-associated chronic colitis. Am J Surg Pathol 1996; 20: 94-102 [PMID: 8540614]
234. Burroughs SH, Bowrey DJ, Morris-Stiff GJ, Williams GT. Granulomatous inflammation in sigmoid diverticulitis: two diseases or one? Histopathology 1998; 33: 349-353 [PMID: 9822925]
235. Warren BF, Shepherd NA, Price AB, Williams GT. Importance of cryptolytic lesions and pericryptal granulomas in inflammatory bowel disease. J Clin Pathol 1997; 50: 880-881 [PMID: 9462279]
236. Warren BF, Shepherd NA. Diversion proctocolitis. Histopathology 1992; 21: 91-93 [PMID: 1634209]
237. Mahadeva U, Martin JP, Patel NK, Price AB. Granulomatous ulcerative colitis: a re-appraisal of the mucosal granuloma in the distinction of Crohn's disease from ulcerative colitis. Histopathology 2002; 41: 50-55 [PMID: 12121237]
238. Lee FD, Maguire C, Obeidat W, Russell RI. Importance of cryptolytic lesions and pericryptal granulomas in inflammatory bowel disease. J Clin Pathol 1997; 50: 148-152 [PMID: 9155697]
239. Bressenot A, Geboes K, Vignaud JM, Guéant JL, Peyrin-Biroulet L. Microscopic features for initial diagnosis and disease activity evaluation in inflammatory bowel disease. Inflamm Bowel Dis 2013; 19: 1745-1752 [PMID: 23782793 DOI: 10.1097/MIB.0b013e318281f2e8]
240. Rubio CA, Orrego A, Nesi G, Finkel Y. Frequency of epithelioid granulomas in colonoscopic biopsy specimens from paediatric and adult patients with Crohn's colitis. J Clin Pathol 2007; 60: 1268-1272 [PMID: 17293387]
241. de Bie CI, Paerregaard A, Kolacek S, Ruemmele FM, Koletzko S, Fell JM, Escher JC. Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis 2013; 19: 378-385 [PMID: 22573581 DOI: 10.1002/ibd.23008]
242. Heresbach D, Alexandre JL, Branger B, Bretagne JF, Cruchant E, Dabadie A, Dartois-Hoguin M, Girardot PM, Jouanolle H, Kerneis J, Le Verger JC, Louvain V, Politis J, Richecoeur M, Robaszkiewicz M, Seyrig JA. Frequency and significance of granulomas in a cohort of incident cases of Crohn's disease. Gut 2005; 54: 215-222 [PMID: 15647184]
243. Guindi M, Riddell RH. Indeterminate colitis. J Clin Pathol 2004; 57: 1233-1244 [PMID: 15563659]
244. Das KM, Vecchi M, Sakamaki S. A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody. Gastroenterology 1990; 98: 464-469 [PMID: 1688539]
245. Yantiss RK, Das KM, Farraye FA, Odze RD. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis. Am J Surg Pathol 2008; 32: 844-850 [PMID: 18408596]
246. Paerregaard A. What does the IBD patient hide in the upper gastrointestinal tract? Inflamm Bowel Dis 2009; 15: 1101-1104 [PMID: 19202573]
247. Kuriyama M, Kato J, Morimoto N, Fujimoto T, Okada H, Yamamoto K. Specific gastroduodenoscopic findings in Crohn's disease: Comparison with findings in patients with ulcerative colitis and gastroesophageal reflux disease. Dig Liver Dis 2008; 40: 468-475 [PMID: 18328794 DOI: 10.1016/j.dld.2008.01.008]
248. Annunziata ML, Caviglia R, Papparella LG, Cicala M. Upper gastrointestinal involvement of Crohn's disease: a prospective study on the role of upper endoscopy in the diagnostic work-up. Dig Dis Sci 2012; 57: 1618-1623 [PMID: 22350786 DOI: 10.1007/s10620-012-2072-0]
249. Rutgeerts P, Onette E, Vantrappen G, Geboes K, Broeckaert L, Talloen L. Crohn's disease of the stomach and duodenum: A clinical study with emphasis on the value of endoscopy and endoscopic biopsies. Endoscopy 1980; 12: 288-294 [PMID: 7428736]
250. Nugent FW, Roy MA. Duodenal Crohn's disease: an analysis of 89 cases. Am J Gastroenterol 1989; 84: 249-254 [PMID: 2919581]
251. Nugent FW, Richmond M, Park SK. Crohn's disease of the duodenum. Gut 1977; 18: 115-120 [PMID: 856671]
252. Wagtmans MJ, Verspaget HW, Lamers CB, van Hogezand RA. Clinical aspects of Crohn's disease of the upper gastrointestinal tract: a comparison with distal Crohn' s disease. Am J Gastroenterol 1997; 92: 1467-1471 [PMID: 9317064]
253. Crocco S, Martelossi S, Giurici N, Villanacci V, Ventura A. Upper gastrointestinal involvement in paediatric onset Crohn's disease: prevalence and clinical implications. J Crohns Colitis 2012; 6: 51-55 [PMID: 22261527]
254. Kovacs M, Muller KE, Arato A, Lakatos PL, Kovacs JB, Varkonyi A, Solyom E, Polgar M, Nemes E, Guthy I, Tokodi I, Toth G, Horvath A, Tarnok A, Tomsits E, Csoszánszky N, Balogh M, Vass N, Bodi P, Dezsofi A, Gardos L, Micskey E, Papp M, Szucs D, Cseh A, Molnar K, Szabo D, Veres G. Diagnostic yield of upper endoscopy in paediatric patients with Crohn's disease and ulcerative colitis. Subanalysis of the HUPIR registry. J Crohns Colitis 2012; 6: 86-94 [PMID: 22261532 DOI: 10.1016/j.crohns.2011.07.008]
255. Oberhuber G, Püspök A, Oesterreicher C, Novacek G, Zauner C, Burghuber M, Vogelsang H, Pötzi R, Stolte M, Wrba F. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology 1997; 112: 698-706 [PMID: 9041230]
256. Parente F, Molteni P, Bollani S, Maconi G, Vago L, Duca PG, Rembacken B, Axon AT, Bianchi Porro G. Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases. A cross-sectional study with matching. Scand J Gastroenterol 1997; 32: 1140-1146 [PMID: 9399396]
257. Wright CL, Riddell RH. Histology of the stomach and duodenum in Crohn's disease. Am J Surg Pathol 1998; 22: 383-390 [PMID: 9537465]
258. Danelius M, Ost A, Lapidus AB. Inflammatory bowel disease-related lesions in the duodenal and gastric mucosa. Scand J Gastroenterol 2009; 44: 441-445 [PMID: 19110988 DOI: 10.1080/00365520802647426]
259. Tobin JM, Sinha B, Ramani P, Saleh AR, Murphy MS. Upper gastrointestinal mucosal disease in pediatric Crohn disease and ulcerative colitis: a blinded, controlled study. J Pediatr Gastroenterol Nutr 2001; 32: 443-448 [PMID: 11396811]
260. Abdullah BA, Gupta SK, Croffie JM, Pfefferkorn MD, Molleston JP, Corkins MR, Fitzgerald JF. The role of esophagogastroduodenoscopy in the initial evaluation of childhood inflammatory bowel disease: a 7-year study. J Pediatr Gastroenterol Nutr 2002; 35: 636-640 [PMID: 12454578]
261. De Matos V, Russo PA, Cohen AB, Mamula P, Baldassano RN, Piccoli DA. Frequency and clinical correlations of granulomas in children with Crohn disease. J Pediatr Gastroenterol Nutr 2008; 46: 392-398 [PMID: 18367950 DOI: 10.1097/MPG.0b013e31812e95e1]
262. Castellaneta SP, Afzal NA, Greenberg M, Deere H, Davies S, Murch SH, Walker-Smith JA, Thomson M, Srivistrava A. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2004; 39: 257-261 [PMID: 15319625]
263. Shaoul R, Karban A, Weiss B, Reif S, Wasserman D, Pacht A, Eliakim R, Wardi J, Shirin H, Wine E, Leshinsky-Silver E, Levine A. NOD2/CARD15 mutations and presence of granulomas in pediatric and adult Crohn's disease. Inflamm Bowel Dis 2004; 10: 709-714 [PMID: 15626887]
264. Ravikumara M, Ashok D, Sandhu BK, Spray CH, Fell JME, Paerregaard A, Murphy MS. Upper gastrointestinal endoscopy is valuable in the diagnosis of Crohn's disease. J Pediatr Gastroenterol Nutr 2006; 43 (suppl 2): S27
265. Hummel TZ, ten Kate FJ, Reitsma JB, Benninga MA, Kindermann A. Additional value of upper GI tract endoscopy in the diagnostic assessment of childhood IBD. J Pediatr Gastroenterol Nutr 2012; 54: 753-757 [PMID: 22584746 DOI: 10.1097/MPG.0b013e318243e3e3]
266. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis - the Porto criteria. J Pediatr Gastroenterol Nutr 2005; 41: 1-7 [PMID: 15990620]
267. Ruuska T, Vaajalahti P, Arajärvi P, Mäki M. Prospective evaluation of upper gastrointestinal mucosal lesions in children with ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr 1994; 19: 181-186 [PMID: 7815240]
268. Maeng L, Lee A, Choi K, Kang CS, Kim KM. Granulomatous gastritis: a clinicopathologic analysis of 18 biopsy cases. Am J Surg Pathol 2004; 28: 941-945 [PMID: 15223966]
269. Wimmer B, Plamenig D, Gilg MM, Fortunat W, Langner C. Granulomatous duodenitis mimicking Crohn's disease caused by Capnocytophaga sp. Inflamm Bowel Dis 2011; 17: E31-E32 [PMID: 21351203 DOI: 10.1002/ibd.21645]
270. Parente F, Cucino C, Bollani S, Imbesi V, Maconi G, Bonetto S, Vago L, Bianchi Porro G. Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role. Am J Gastroenterol 2000; 95: 705-711 [PMID: 10710061]
271. Sonnenberg A, Melton SD, Genta RM. Frequent occurrence of gastritis and duodenitis in patients with inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 39-44 [PMID: 20848539]
272. Ebach DR, Vanderheyden AD, Ellison JM, Jensen CS. Lymphocytic esophagitis: a possible manifestation of pediatric upper gastrointestinal Crohn's disease. Inflamm Bowel Dis 2011; 17: 45-49 [PMID: 20848529 DOI: 10.1002/ibd.21347]
273. Sharif F, McDermott M, Dillon M, Drumm B, Rowland M, Imrie C, Kelleher S, Harty S, Bourke B. Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis. Am J Gastroenterol 2002; 97: 1415-1420 [PMID: 12094859]
274. McHugh JB, Gopal P, Greenson JK. The clinical significance of focally enhanced gastritis in children. Am J Surg Pathol 2013; 37: 295-299 [PMID: 23108022 DOI: 10.1097/PAS.0b013e31826b2a94]
275. Roka K, Roma E, Stefanaki K, Panayotou I, Kopsidas G, Chouliaras G. The value of focally enhanced gastritis in the diagnosis of pediatric inflammatory bowel diseases. J Crohns Colitis 2013; 7: 797-802 [PMID: 23207168 DOI: 10.1016/j.crohns.2012.11.003]
276. Honma J, Mitomi H, Murakami K, Igarashi M, Saigenji K, Toyama K. Nodular duodenitis involving CD8+ cell infiltration in patients with ulcerative colitis. Hepatogastroenterology 2001; 48: 1604-1610 [PMID: 11813583]
277. Hori K, Ikeuchi H, Nakano H, Uchino M, Tomita T, Ohda Y, Hida N, Matsumoto T, Fukuda Y, Miwa H. Gastroduodenitis associated with ulcerative colitis. J Gastroenterol 2008; 43: 193-201 [PMID: 18373161 DOI: 10.1007/s00535-007-2143-8]
278. Lin J, McKenna BJ, Appelman HD. Morphologic findings in upper gastrointestinal biopsies of patients with ulcerative colitis: a controlled study. Am J Surg Pathol 2010; 34: 1672-1677 [PMID: 20962621 DOI: 10.1097/PAS.0b013e3181f3de93]
279. Korelitz BI, Waye JD, Kreuning J, Sommers SC, Fein HD, Beeber J, Gelberg BJ. Crohn's disease in endoscopic biopsies of the gastric antrum and duodenum. Am J Gastroenterol 1981; 76: 103-109 [PMID: 7304545]
280. Cameron DJ. Upper and lower gastrointestinal endoscopy in children and adolescents with Crohn's disease: a prospective study. J Gastroenterol Hepatol 1991; 6: 355-358 [PMID: 1912443]
281. Srivastava A, Lauwers GY. Pathology of non-infective gastritis. Histopathology 2007; 50: 15-29 [PMID: 17204018]
282. Xin W, Greenson JK. The clinical significance of focally enhanced gastritis. Am J Surg Pathol 2004; 28: 1347-1351 [PMID: 15371951]
283. Flamant M, Trang C, Maillard O, Sacher-Huvelin S, Le Rhun M, Galmiche JP, Bourreille A. The prevalence and outcome of jejunal lesions visualized by small bowel capsule endoscopy in Crohn's disease. Inflamm Bowel Dis 2013; 19: 1390-1396 [PMID: 23552764 DOI: 10.1097/MIB.0b013e31828133c1]
284. Kornbluth A, Colombel JF, Leighton JA, Loftus E. ICCE consensus for inflammatory bowel disease. Endoscopy 2005; 37: 1051-1054 [PMID: 16189789]
285. Tukey M, Pleskow D, Legnani P, Cheifetz AS, Moss AC. The utility of capsule endoscopy in patients with suspected Crohn's disease. Am J Gastroenterol 2009; 104: 2734-2739 [PMID: 19584828 DOI: 10.1038/ajg.2009.404]
286. Rosa B, Moreira MJ, Rebelo A, Cotter J. Lewis Score: a useful clinical tool for patients with suspected Crohn's Disease submitted to capsule endoscopy. J Crohns Colitis 2012; 6: 692-697 [PMID: 22398099 DOI: 10.1016/j.crohns.2011.12.002]
287. Eliakim R, Carter D. Endoscopic assessment of the small bowel. Dig Dis 2013; 31: 194-198 [PMID: 24030224 DOI: 10.1159/000353367]
288. Girelli CM, Porta P, Malacrida V, Barzaghi F, Rocca F. Clinical outcome of patients examined by capsule endoscopy for suspected small bowel Crohn's disease. Dig Liver Dis 2007; 39: 148-154 [PMID: 17196893]
289. Eliakim R. Video capsule endoscopy of the small bowel. Curr Opin Gastroenterol 2013; 29: 133-139 [PMID: 23221650 DOI: 10.1097/MOG.0b013e32835bdc03]
290. Cotter J, Dias de Castro F, Moreira MJ, Rosa B. Tailoring Crohn's disease treatment: The impact of small bowel capsule endoscopy. J Crohns Colitis 2014; 8: 1610-1615 [PMID: 24631311 DOI: 10.1016/j.crohns.2014.02.018]
291. Dionisio PM, Gurudu SR, Leighton JA, Leontiadis GI, Fleischer DE, Hara AK, Heigh RI, Shiff AD, Sharma VK. Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and established small-bowel Crohn's disease: a meta-analysis. Am J Gastroenterol 2010; 105: 1240-1248; quiz 1249 [PMID: 20029412 DOI: 10.1038/ajg.2009.713]
292. Cullen G, Donnellan F, Doherty GA, Smith M, Cheifetz AS. Evaluation of the small bowel in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2013; 7: 239-251 [PMID: 23445233 DOI: 10.1586/egh.13.11]
293. Mow WS, Lo SK, Targan SR, Dubinsky MC, Treyzon L, Abreu-Martin MT, Papadakis KA, Vasiliauskas EA. Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol 2004; 2: 31-40 [PMID: 15017630]
294. Doherty GA, Moss AC, Cheifetz AS. Capsule endoscopy in suspected Crohn's disease: "yield" does not equal "diagnosis". Am J Gastroenterol 2010; 105: 2111; author reply 2111-2112 [PMID: 20818355 DOI: 10.1038/ajg.2010.203]
295. Rondonotti E, Villa F, Mulder CJ, Jacobs MA, de Franchis R. Small bowel capsule endoscopy in 2007: indications, risks and limitations. World J Gastroenterol 2007; 13: 6140-6149 [PMID: 18069752]
296. Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005; 3: 133-141 [PMID: 15704047]
297. Dost D, van Leerdam ME, van Dekken H, Weimar W, Kuipers EJ, Bijl AH, van Gelder T. Crohn's-like enterocolitis associated with mycophenolic acid treatment. Gut 2008; 57: 1330 [PMID: 18719142 DOI: 10.1136/gut.2007.139972]
298. Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 2005; 128: 1172-1178 [PMID: 15887101]
299. Matsumoto T, Iida M, Matsui T, Yao T. Chronic nonspecific multiple ulcers of the small intestine: a proposal of the entity from Japanese gastroenterologists to Western enteroscopists. Gastrointest Endosc 2007; 66: S99-107 [PMID: 17709045]
300. Maunoury V, Savoye G, Bourreille A, Bouhnik Y, Jarry M, Sacher-Huvelin S, Ben Soussan E, Lerebours E, Galmiche JP, Colombel JF. Value of wireless capsule endoscopy in patients with indeterminate colitis (inflammatory bowel disease type unclassified). Inflamm Bowel Dis 2007; 13: 152-155 [PMID: 17206697]
301. Lopes S, Figueiredo P, Portela F, Freire P, Almeida N, Lérias C, Gouveia H, Leitão MC. Capsule endoscopy in inflammatory bowel disease type unclassified and indeterminate colitis serologically negative. Inflamm Bowel Dis 2010; 16: 1663-1668 [PMID: 20848457 DOI: 10.1002/ibd.21249]
302. Mehdizadeh S, Chen G, Enayati PJ, Cheng DW, Han NJ, Shaye OA, Ippoliti A, Vasiliauskas EA, Lo SK, Papadakis KA. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU). Endoscopy 2008; 40: 30-35 [PMID: 18058654]
303. Di Nardo G, Oliva S, Ferrari F, Riccioni ME, Staiano A, Lombardi G, Costamagna G, Cucchiara S, Stronati L. Usefulness of wireless capsule endoscopy in paediatric inflammatory bowel disease. Dig Liver Dis 2011; 43: 220-224 [PMID: 21093392 DOI: 10.1016/j.dld.2010.10.004]
304. Hisabe T, Ninomiya K, Matsui T, Karashima Y, Sato Y, Nagahama T, Takaki Y, Hirai F, Yao K, Higashi D, Futami K, Iwashita A. Small bowel lesions detected with wireless capsule endoscopy in patients with active ulcerative colitis and with post-proctocolectomy. Dig Endosc 2011; 23: 302-309 [PMID: 21951090 DOI: 10.1111/j.1443-1661.2011.01149.x]
305. Higurashi T, Endo H, Yoneda M, Hosono K, Sakai E, Takahashi H, Inamori M, Uchiyama S, Kojima T, Kawana K, Natsumeda Y, Nagase H, Nakajima A. Capsule-endoscopic findings of ulcerative colitis patients. Digestion 2011; 84: 306-314 [PMID: 22041924 DOI: 10.1159/000333086]
306. Kalla R, McAlindon ME, Drew K, Sidhu R. Clinical utility of capsule endoscopy in patients with Crohn's disease and inflammatory bowel disease unclassified. Eur J Gastroenterol Hepatol 2013; 25: 706-713 [PMID: 23325280 DOI: 10.1097/MEG.0b013e32835ddb85]
307. Murrell Z, Vasiliauskas E, Melmed G, Lo S, Targan S, Fleshner P. Preoperative wireless capsule endoscopy does not predict outcome after ileal pouch-anal anastomosis. Dis Colon Rectum 2010; 53: 293-300 [PMID: 20173476 DOI: 10.1007/DCR.0b013e3181b71a2c]
308. Iacucci M, Panaccione R, Ghosh S. Advances in novel diagnostic endoscopic imaging techniques in inflammatory bowel disease. Inflamm Bowel Dis 2013; 19: 873-880 [PMID: 23448788 DOI: 10.1097/MIB.0b013e318280143f]
309. Neumann H, Neurath MF. Colonoscopy, inflammatory bowel disease. Endoscopy 2014; 46: 322-326 [PMID: 24648199 DOI: 10.1055/s-0034-1365297]
310. Subramanian V, Ragunath K. Advanced endoscopic imaging: a review of commercially available technologies. Clin Gastroenterol Hepatol 2014; 12: 368-376.e1 [PMID: 23811245 DOI: 10.1016/j.cgh.2013.06.015]
311. Sharma P, Gupta N, Kuipers EJ, Repici A, Wallace M. Advanced imaging in colonoscopy and its impact on quality. Gastrointest Endosc 2014; 79: 28-36 [PMID: 24119713 DOI: 10.1016/j.gie.2013.08.020]
312. Subramanian V, Ramappa V, Telakis E, Mannath J, Jawhari AU, Hawkey CJ, Ragunath K. Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease. Inflamm Bowel Dis 2013; 19: 350-355 [PMID: 22552948 DOI: 10.1002/ibd.23002]
313. Gross SA, Buchner AM, Crook JE, Cangemi JR, Picco MF, Wolfsen HC, DeVault KR, Loeb DS, Raimondo M, Woodward TA, Wallace MB. A comparison of high definition-image enhanced colonoscopy and standard whitelight colonoscopy for colorectal polyp detection. Endoscopy 2011; 43: 1045-1051 [PMID: 21971929 DOI: 10.1055/s-0030-1256894]
314. Nishio Y, Ando T, Maeda O, Ishiguro K, Watanabe O, Ohmiya N, Niwa Y, Kusugami K, Goto H. Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis. Gut 2006; 55: 1768-1773 [PMID: 16682428]
315. Kunihiro M, Tanaka S, Sumii M, Ueno Y, Ito M, Kitadai Y, Yoshihara M, Shimamoto F, Haruma K, Chayama K. Magnifying colonoscopic features of ulcerative colitis reflect histologic inflammation. Inflamm Bowel Dis 2004; 10: 737-744 [PMID: 15626891]
316. Fujiya M, Saitoh Y, Nomura M, Maemoto A, Fujiya K, Watari J, Ashida T, Ayabe T, Obara T, Kohgo Y. Minute findings by magnifying colonoscopy are useful for the evaluation of ulcerative colitis. Gastrointest Endosc 2002; 56: 535-542 [PMID: 12297770]
317. Neumann H, Vieth M, Günther C, Neufert C, Kiesslich R, Grauer M, Atreya R, Neurath MF. Virtual chromoendoscopy for prediction of severity and disease extent in patients with inflammatory bowel disease: a randomized controlled study. Inflamm Bowel Dis 2013; 19: 1935-1942 [PMID: 23839228 DOI: 10.1097/MIB.0b013e318290550e]
318. Tontini GE, Vecchi M, Neurath MF, Neumann H. Review article: newer optical and digital chromoendoscopy techniques vs. dye-based chromoendoscopy for diagnosis and surveillance in inflammatory bowel disease. Aliment Pharmacol Ther 2013; 38: 1198-1208 [PMID: 24117471 DOI: 10.1111/apt.12508]
319. Watanabe O, Ando T, Maeda O, Hasegawa M, Ishikawa D, Ishiguro K, Ohmiya N, Niwa Y, Goto H. Confocal endomicroscopy in patients with ulcerative colitis. J Gastroenterol Hepatol 2008; 23 Suppl 2: S286-S290 [PMID: 19120913 DOI: 10.1111/j.1440-1746.2008.05559.x]
320. Trovato C, Sonzogni A, Fiori G, Ravizza D, Tamayo D, Botti F, Carrara A, Zefelippo A, Contessini-Avesani E, Crosta C. Confocal laser endomicroscopy for the detection of mucosal changes in ileal pouch after restorative proctocolectomy. Dig Liver Dis 2009; 41: 578-585 [PMID: 19013113 DOI: 10.1016/j.dld.2008.09.019]
321. Neumann H, Kiesslich R, Wallace MB, Neurath MF. Confocal laser endomicroscopy: technical advances and clinical applications. Gastroenterology 2010; 139: 388-392, 392.e1-2 [PMID: 20561523 DOI: 10.1053/j.gastro.2010.06.029]
322. Li CQ, Xie XJ, Yu T, Gu XM, Zuo XL, Zhou CJ, Huang WQ, Chen H, Li YQ. Classification of inflammation activity in ulcerative colitis by confocal laser endomicroscopy. Am J Gastroenterol 2010; 105: 1391-1396 [PMID: 19935787 DOI: 10.1038/ajg.2009.664]
323. Liu JJ, Wong K, Thiesen AL, Mah SJ, Dieleman LA, Claggett B, Saltzman JR, Fedorak RN. Increased epithelial gaps in the small intestines of patients with inflammatory bowel disease: density matters. Gastrointest Endosc 2011; 73: 1174-1180 [PMID: 21396639 DOI: 10.1016/j.gie.2011.01.018]
324. Neumann H, Vieth M, Atreya R, Grauer M, Siebler J, Bernatik T, Neurath MF, Mudter J. Assessment of Crohn's disease activity by confocal laser endomicroscopy. Inflamm Bowel Dis 2012; 18: 2261-2269 [PMID: 22344873 DOI: 10.1002/ibd.22907]
325. Kiesslich R, Duckworth CA, Moussata D, Gloeckner A, Lim LG, Goetz M, Pritchard DM, Galle PR, Neurath MF, Watson AJ. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 2012; 61: 1146-1153 [PMID: 22115910 DOI: 10.1136/gutjnl-2011-300695]
326. Liu J, Dlugosz A, Neumann H. Beyond white light endoscopy: the role of optical biopsy in inflammatory bowel disease. World J Gastroenterol 2013; 19: 7544-7551 [PMID: 24282344 DOI: 10.3748/wjg.v19.i43.7544]
327. Buda A, Hatem G, Neumann H, D'Incà R, Mescoli C, Piselli P, Jackson J, Bruno M, Sturniolo GC. Confocal laser endomicroscopy for prediction of disease relapse in ulcerative colitis: a pilot study. J Crohns Colitis 2014; 8: 304-311 [PMID: 24094597 DOI: 10.1016/j.crohns.2013.09.005]
328. Neumann H, Kiesslich R. Endomicroscopy and endocytoscopy in IBD. Gastrointest Endosc Clin N Am 2013; 23: 695-705 [PMID: 23735111 DOI: 10.1016/j.giec.2013.03.006]
329. Neumann H, Vieth M, Neurath MF, Atreya R. Endocytoscopy allows accurate in vivo differentiation of mucosal inflammatory cells in IBD: a pilot study. Inflamm Bowel Dis 2013; 19: 356-362 [PMID: 22644957 DOI: 10.1002/ibd.23025]
330. Tontini GE, Mudter J, Vieth M, Atreya R, Günther C, Zopf Y, Wildner D, Kiesslich R, Vecchi M, Neurath MF, Neumann H. Confocal laser endomicroscopy for the differential diagnosis of ulcerative colitis and Crohn's disease: a pilot study. Endoscopy 2014 [DOI: 10.1055/s-0034-1391226]
331. Zipfel WR, Williams RM, Webb WW. Nonlinear magic: multiphoton microscopy in the biosciences. Nat Biotechnol 2003; 21: 1369-1377 [PMID: 14595365]
332. Schürmann S, Foersch S, Atreya R, Neumann H, Friedrich O, Neurath MF, Waldner MJ. Label-free imaging of inflammatory bowel disease using multiphoton microscopy. Gastroenterology 2013; 145: 514-516 [PMID: 23850960 DOI: 10.1053/j.gastro.2013.06.054]
333. Atreya R, Goetz M. Molecular imaging in gastroenterology. Nat Rev Gastroenterol Hepatol 2013; 10: 704-712 [PMID: 23856892 DOI: 10.1038/nrgastro.2013.125]
334. Atreya R, Neumann H, Neufert C, Waldner MJ, Billmeier U, Zopf Y, Willma M, App C, Münster T, Kessler H, Maas S, Gebhardt B, Heimke-Brinck R, Reuter E, Dörje F, Rau TT, Uter W, Wang TD, Kiesslich R, Vieth M, Hannappel E, Neurath MF. In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease. Nat Med 2014; 20: 313-318 [PMID: 24562382 DOI: 10.1038/nm.3462]
335. Kutsukawa M, Kudo SE, Ikehara N, Ogawa Y, Wakamura K, Mori Y, Ichimasa K, Misawa M, Kudo T, Wada Y, Hayashi T, Miyachi H, Inoue H, Hamatani S. Efficiency of endocytoscopy in differentiating types of serrated polyps. Gastrointest Endosc 2014; 79: 648-656 [PMID: 24119508 DOI: 10.1016/j.gie.2013.08.029]
336. Cipolletta L, Bianco MA, Rotondano G, Piscopo R, Meucci C, Prisco A, Cipolletta F, de Gregorio A, Salvati A. Endocytoscopy can identify dysplasia in aberrant crypt foci of the colorectum: a prospective in vivo study. Endoscopy 2009; 41: 129-132 [PMID: 19214891 DOI: 10.1055/s-0028-1103452]
337. Pohl H, Rösch T, Tanczos BT, Rudolph B, Schlüns K, Baumgart DC. Endocytoscopy for the detection of microstructural features in adult patients with celiac sprue: a prospective, blinded endocytoscopy-conventional histology correlation study. Gastrointest Endosc 2009; 70: 933-941 [PMID: 19560762 DOI: 10.1016/j.gie.2009.04.043]
338. Kirtane TS, Wagh MS. Endoscopic Optical Coherence Tomography (OCT): Advances in Gastrointestinal Imaging. Gastroenterol Res Pract 2014; 2014: 376367 [PMID: 24719611 DOI: 10.1155/2014/376367]
339. ASGE Technology Committee . Enhanced imaging in the GI tract: spectroscopy and optical coherence tomography. Gastrointest Endosc 2013; 78: 568-573 [PMID: 24054739 DOI: 10.1016/j.gie.2013.07.024]
340. Familiari L, Strangio G, Consolo P, Luigiano C, Bonica M, Barresi G, Barresi V, Familiari P, D'Arrigo G, Alibrandi A, Zirilli A, Fries W, Scaffidi M. Optical coherence tomography evaluation of ulcerative colitis: the patterns and the comparison with histology. Am J Gastroenterol 2006; 101: 2833-2840 [PMID: 17227526]
341. Shen B, Zuccaro G, Gramlich TL, Gladkova N, Trolli P, Kareta M, Delaney CP, Connor JT, Lashner BA, Bevins CL, Feldchtein F, Remzi FH, Bambrick ML, Fazio VW. In vivo colonoscopic optical coherence tomography for transmural inflammation in inflammatory bowel disease. Clin Gastroenterol Hepatol 2004; 2: 1080-1087 [PMID: 15625653]
342. Bi X, Walsh A, Mahadevan-Jansen A, Herline A. Development of spectral markers for the discrimination of ulcerative colitis and Crohn's disease using Raman spectroscopy. Dis Colon Rectum 2011; 54: 48-53 [PMID: 21160313 DOI: 10.1007/DCR.0b013e3181fcf68d]
343. Ellinghaus D, Zhang H, Zeissig S, Lipinski S, Till A, Jiang T, Stade B, Bromberg Y, Ellinghaus E, Keller A, Rivas MA, Skieceviciene J, Doncheva NT, Liu X, Liu Q, Jiang F, Forster M, Mayr G, Albrecht M, Häsler R, Boehm BO, Goodall J, Berzuini CR, Lee J, Andersen V, Vogel U, Kupcinskas L, Kayser M, Krawczak M, Nikolaus S, Weersma RK, Ponsioen CY, Sans M, Wijmenga C, Strachan DP, McArdle WL, Vermeire S, Rutgeerts P, Sanderson JD, Mathew CG, Vatn MH, Wang J, Nöthen MM, Duerr RH, Büning C, Brand S, Glas J, Winkelmann J, Illig T, Latiano A, Annese V, Halfvarson J, D'Amato M, Daly MJ, Nothnagel M, Karlsen TH, Subramani S, Rosenstiel P, Schreiber S, Parkes M, Franke A. Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies. Gastroenterology 2013; 145: 339-347 [PMID: 23624108 DOI: 10.1053/j.gastro.2013.04.040]
344. Cleynen I, González JR, Figueroa C, Franke A, McGovern D, Bortlík M, Crusius BJ, Vecchi M, Artieda M, Szczypiorska M, Bethge J, Arteta D, Ayala E, Danese S, van Hogezand RA, Panés J, Peña SA, Lukas M, Jewell DP, Schreiber S, Vermeire S, Sans M. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project. Gut 2013; 62: 1556-1565 [PMID: 23263249 DOI: 10.1136/gutjnl-2011-300777]
345. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Büning C, Cohain A, Cichon S, D' Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H; International IBD Genetics Consortium (IIBDGC), Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-124 [PMID: 23128233 DOI: 10.1038/nature11582]
346. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, Lagacé C, Scott R, Amininejad L, Bumpstead S, Baidoo L, Baldassano RN, Barclay M, Bayless TM, Brand S, Büning C, Colombel JF, Denson LA, De Vos M, Dubinsky M, Edwards C, Ellinghaus D, Fehrmann RS, Floyd JA, Florin T, Franchimont D, Franke L, Georges M, Glas J, Glazer NL, Guthery SL, Haritunians T, Hayward NK, Hugot JP, Jobin G, Laukens D, Lawrance I, Lémann M, Levine A, Libioulle C, Louis E, McGovern DP, Milla M, Montgomery GW, Morley KI, Mowat C, Ng A, Newman W, Ophoff RA, Papi L, Palmieri O, Peyrin-Biroulet L, Panés J, Phillips A, Prescott NJ, Proctor DD, Roberts R, Russell R, Rutgeerts P, Sanderson J, Sans M, Schumm P, Seibold F, Sharma Y, Simms LA, Seielstad M, Steinhart AH, Targan SR, van den Berg LH, Vatn M, Verspaget H, Walters T, Wijmenga C, Wilson DC, Westra HJ, Xavier RJ, Zhao ZZ, Ponsioen CY, Andersen V, Torkvist L, Gazouli M, Anagnou NP, Karlsen TH, Kupcinskas L, Sventoraityte J, Mansfield JC, Kugathasan S, Silverberg MS, Halfvarson J, Rotter JI, Mathew CG, Griffiths AM, Gearry R, Ahmad T, Brant SR, Chamaillard M, Satsangi J, Cho JH, Schreiber S, Daly MJ, Barrett JC, Parkes M, Annese V, Hakonarson H, Radford-Smith G, Duerr RH, Vermeire S, Weersma RK, Rioux JD. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011; 43: 246-52 [PMID: 21297633 DOI: 10.1038/ng.764]
347. Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009; 58: 1152-1167 [PMID: 19592695 DOI: 10.1136/gut.2008.163667]
348. Granlund Av, Flatberg A, Ostvik AE, Drozdov I, Gustafsson BI, Kidd M, Beisvag V, Torp SH, Waldum HL, Martinsen TC, Damas JK, Espevik T, Sandvik AK. Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis. PLoS One 2013; 8: e56818 [PMID: 23468882 DOI: 10.1371/journal.pone.0056818]
349. Kaser A, Pasaniuc B. IBD genetics: focus on (dys) regulation in immune cells and the epithelium. Gastroenterology 2014; 146: 896-899 [PMID: 24566108 DOI: 10.1053/j.gastro.2014.02.023]
350. Mokry M, Middendorp S, Wiegerinck CL, Witte M, Teunissen H, Meddens CA, Cuppen E, Clevers H, Nieuwenhuis EE. Many inflammatory bowel disease risk loci include regions that regulate gene expression in immune cells and the intestinal epithelium. Gastroenterology 2014; 146: 1040-1047 [PMID: 24333384 DOI: 10.1053/j.gastro.2013.12.003]
351. Ventham NT, Kennedy NA, Nimmo ER, Satsangi J. Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology 2013; 145: 293-308 [PMID: 23751777 DOI: 10.1053/j.gastro.2013.05.050]
352. Pastorelli L, De Salvo C, Mercado JR, Vecchi M, Pizarro TT. Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics. Front Immunol 2013; 4: 280 [PMID: 24062746 DOI: 10.3389/fimmu.2013.00280]
353. Murthy A, Li Y, Peng I, Reichelt M, Katakam AK, Noubade R, Roose-Girma M, DeVoss J, Diehl L, Graham RR, van Lookeren Campagne M. A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3. Nature 2014; 506: 456-462 [PMID: 24553140 DOI: 10.1038/nature13044]
354. Van Limbergen J, Radford-Smith G, Satsangi J. Advances in IBD genetics. Nat Rev Gastroenterol Hepatol 2014; 11: 372-385 [PMID: 24614343 DOI: 10.1038/nrgastro.2014.27]
355. Wu F, Dassopoulos T, Cope L, Maitra A, Brant SR, Harris ML, Bayless TM, Parmigiani G, Chakravarti S. Genomewide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis 2007; 13: 807-821 [PMID: 17262812]
356. von Stein P, Lofberg R, Kuznetsov NV, Gielen AW, Persson JO, Sundberg R, Hellstrom K, Eriksson A, Befrits R, Ost A, von Stein OD. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome. Gastroenterology 2008; 134: 1869-1881; quiz 2153-2154 [PMID: 18466904 DOI: 10.1053/j.gastro.2008.02.083]
357. von Stein OD. Isolation of differentially expressed genes through subtractive suppression hybridization. Methods Mol Biol 2001; 175: 263-278 [PMID: 11462840]
358. Janczewska I, Kapraali M, Saboonchi F, Nekzada Q, Wessulv A, Khoshkar J, Marouf F, Gorsetman J, Risberg D, Lissing M, Wirström G, Sandstedt B. Clinical application of the multigene analysis test in discriminating between ulcerative colitis and Crohn's disease: a retrospective study. Scand J Gastroenterol 2012; 47: 162-169 [PMID: 22229803 DOI: 10.3109/00365521.2011.647065]
359. Huett A, Xavier RJ. Neither hide nor hair: the difficulty of identifying useful disease biomarkers. Gastroenterology 2008; 134: 2164-2168 [PMID: 18486617 DOI: 10.1053/j.gastro.2008.04.013]
360. Stylianou E. Epigenetics: the fine-tuner in inflammatory bowel disease? Curr Opin Gastroenterol 2013; 29: 370-377 [PMID: 23743674 DOI: 10.1097/MOG.0b013e328360bd12]
361. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001; 61: 3573-3577 [PMID: 11325821]
362. Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, Bayless TM, Brant SR, Chakravarti S, Kwon JH. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008; 135: 1624-1635.e24 [PMID: 18835392 DOI: 10.1053/j.gastro.2008.07.068]
363. Olsen J, Gerds TA, Seidelin JB, Csillag C, Bjerrum JT, Troelsen JT, Nielsen OH. Diagnosis of ulcerative colitis before onset of inflammation by multivariate modeling of genome-wide gene expression data. Inflamm Bowel Dis 2009; 15: 1032-1038 [PMID: 19177426 DOI: 10.1002/ibd.20879]
364. Coskun M, Bjerrum JT, Seidelin JB, Troelsen JT, Olsen J, Nielsen OH. miR-20b, miR-98, miR-125b-1∗, and let-7e∗ as new potential diagnostic biomarkers in ulcerative colitis. World J Gastroenterol 2013; 19: 4289-4299 [PMID: 23885139 DOI: 10.3748/wjg.v19.i27.4289]
365. Zahm AM, Thayu M, Hand NJ, Horner A, Leonard MB, Friedman JR. Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2011; 53: 26-33 [PMID: 21546856 DOI: 10.1097/MPG.0b013e31822200cc]
366. Wu F, Guo NJ, Tian H, Marohn M, Gearhart S, Bayless TM, Brant SR, Kwon JH. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 2011; 17: 241-250 [PMID: 20812331 DOI: 10.1002/ibd.21450]
367. Paraskevi A, Theodoropoulos G, Papaconstantinou I, Mantzaris G, Nikiteas N, Gazouli M. Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis 2012; 6: 900-904 [PMID: 22386737 DOI: 10.1016/j.crohns.2012.02.006]
368. Palsson B. Metabolic systems biology. FEBS Lett 2009; 583: 3900-3904 [PMID: 19769971 DOI: 10.1016/j.febslet.2009.09.031]
369. Nicholson JK, Lindon JC. Systems biology: Metabonomics. Nature 2008; 455: 1054-1056 [PMID: 18948945 DOI: 10.1038/4551054a]
370. Roda G, Caponi A, Benevento M, Nanni P, Mezzanotte L, Belluzzi A, Mayer L, Roda A. New proteomic approaches for biomarker discovery in inflammatory bowel disease. Inflamm Bowel Dis 2010; 16: 1239-1246 [PMID: 20127998 DOI: 10.1002/ibd.21212]
371. Storr M, Vogel HJ, Schicho R. Metabolomics: is it useful for inflammatory bowel diseases? Curr Opin Gastroenterol 2013; 29: 378-383 [PMID: 23624676 DOI: 10.1097/MOG.0b013e328361f488]
372. Bennike T, Birkelund S, Stensballe A, Andersen V. Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies. World J Gastroenterol 2014; 20: 3231-3244 [PMID: 24696607 DOI: 10.3748/wjg.v20.i12.3231]
373. Hatsugai M, Kurokawa MS, Kouro T, Nagai K, Arito M, Masuko K, Suematsu N, Okamoto K, Itoh F, Kato T. Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohn' s disease. J Gastroenterol 2010; 45: 488-500 [PMID: 20049485 DOI: 10.1007/s00535-009-0183-y]
374. Sharma U, Singh RR, Ahuja V, Makharia GK, Jagannathan NR. Similarity in the metabolic profile in macroscopically involved and un-involved colonic mucosa in patients with inflammatory bowel disease: an in vitro proton ((1)H) MR spectroscopy study. Magn Reson Imaging 2010; 28: 1022-1029 [PMID: 20418044 DOI: 10.1016/j.mri.2010.03.039]
375. Seeley EH, Washington MK, Caprioli RM, M'Koma AE. Proteomic patterns of colonic mucosal tissues delineate Crohn's colitis and ulcerative colitis. Proteomics Clin Appl 2013; 7: 541-549 [PMID: 23382084 DOI: 10.1002/prca.201200107]
376. M'Koma AE, Seeley EH, Washington MK, Schwartz DA, Muldoon RL, Herline AJ, Wise PE, Caprioli RM. Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides. Inflamm Bowel Dis 2011; 17: 875-883 [PMID: 20806340 DOI: 10.1002/ibd.21442]
377. Poulsen NA, Andersen V, Moller JC, Moller HS, Jessen F, Purup S, Larsen LB. Comparative analysis of inflamed and non-inflamed colon biopsies reveals strong proteomic inflammation profile in patients with ulcerative colitis. BMC Gastroenterol 2012; 12: 76 [PMID: 22726388 DOI: 10.1186/1471-230X-12-76]
378. Fiocchi C . Inflammatory bowel disease: evolutionary concepts in biology, epidemiology, mechanisms and therapy. Curr Opin Gastroenterol 2013; 29: 347-349 [PMID: 23666367]